BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9845473)

  • 1. Failure to respond to interferon-alpha 2a therapy is associated with increased hepatic iron levels in patients with chronic hepatitis C.
    Kageyama F; Kobayashi Y; Murohisa G; Shimizu E; Suzuki F; Kikuyama M; Souda K; Kawasaki T; Nakamura H
    Biol Trace Elem Res; 1998; 64(1-3):185-96. PubMed ID: 9845473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
    Pianko S; McHutchison JG; Gordon SC; Heaton S; Goodman ZD; Patel K; Cortese CM; Brunt EM; Bacon BR; Blatt LM
    J Interferon Cytokine Res; 2002 Apr; 22(4):483-9. PubMed ID: 12034031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
    J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
    Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.
    Izumi N; Enomoto N; Uchihara M; Murakami T; Ono K; Noguchi O; Miyake S; Nouchi T; Fujisawa K; Marumo F; Sato C
    Dig Dis Sci; 1996 May; 41(5):989-94. PubMed ID: 8625774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.
    Olynyk JK; Reddy KR; Di Bisceglie AM; Jeffers LJ; Parker TI; Radick JL; Schiff ER; Bacon BR
    Gastroenterology; 1995 Apr; 108(4):1104-9. PubMed ID: 7698578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
    Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
    Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
    Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
    Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
    Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
    Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of iron load on fibrogenesis in chronic hepatitis C.
    Casaril M; Stanzial AM; Tognella P; Pantalena M; Capra F; Colombari R; Corrocher R
    Hepatogastroenterology; 2000; 47(31):220-5. PubMed ID: 10690612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver.
    Kakizaki S; Takagi H; Ichikawa T; Abe T; Yamada T; Suzuki K; Kojima A; Takayama H; Takezawa J; Nagamine T; Mori M
    Biol Trace Elem Res; 2000 Feb; 73(2):151-62. PubMed ID: 11049207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
    El Raziky M; Elsharkawy A; Said SE; Abdelatty S; El Akel W; Tantawy O; Gamal Eldeen H; Mabrouk M
    J Interferon Cytokine Res; 2015 Aug; 35(8):649-53. PubMed ID: 25973761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection.
    Arber N; Moshkowitz M; Konikoff F; Halpern Z; Hallak A; Santo M; Tiomny E; Baratz M; Gilat T
    Dig Dis Sci; 1995 Nov; 40(11):2431-3. PubMed ID: 7587826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.